Accessibility of abciximab to megakaryocytes and endothelial cells in the bone marrow compartment: Studies on a patient receiving antithrombotic therapy

British Journal of Haematology

Volumn 107, Issue 3, 1999, Pages 526-531

  Poujol, Christel ^b   Durrieu Jais, Catherine ^a,b   Larrue, Benoit ^a,b   Nurden, Alan T ^b   Nurden, Paquita ^a,b  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b UMR 5533 CNRS   (France)

Author keywords

Abciximab; Endothelial cells; Immuno electron microscopy; Megakaryocytes; Platelet production

Indexed keywords

ABCIXIMAB;

ANTICOAGULANT THERAPY; ARTICLE; BONE MARROW; DRUG DISTRIBUTION; ENDOTHELIUM CELL; HUMAN; MEGAKARYOCYTE; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0032731205     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01740.x     Document Type: Article

References (18)

1. Bednar, B., Bednar, R.A., Cook, J.J., Bollag, D.M., Chang, C.T., Gaul, S.L., McQueney, P.A., Egbertson, M.S., Hartman, G.D., Holahan, M.A., Lynch, J.J. & Gould, R.J. (1996) Drug-dependent antibodies against glycoprotein IIb/IIIa induce thrombocytopenia. (Abstract). Circulation, 94, (Suppl. I), 99.
2. Berkowitz, S.D., Harrington, R.A., Rund, M.M. & Tcheng, J.E. (1997) Acute profound thrombocytopenia after c7E3 Fab (abciximab) therapy. Circulation, 95, 809-813.
3. Bihour, C., Durrieu-Jais, C., Macchi, L., Poujol, C., Coste, P., Besse, P., Nurden, P. & Nurden, A.T. (1999) Expression of markers of platelet activation and the interpatient variation in response to abciximab. Arteriosclerosis and Thrombosis Vascular Biology. 19, 212-219.
4. Christopoulos, C., Mackie, I., Lahiri, A. & Machin, S. (1993) Flow cytometric observations on the in vivo use of Fab fragments of a chimaeric monoclonal antibody to platelet glycoprotein IIb-IIIa. Blood Coagulation and Fibrinolysis, 4, 729-737.
5. Coller, B.S. (1985) A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or micro-environment of the platelet glycoprotein IIb/IIIa complex. Journal of Clinical Investigation, 76, 101-108.
6. Coller, B.S. (1997) Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. Journal of Clinical Investigation, 99, 1467-1471.
7. Conforti, G., Dominguez-Jimenez, C., Zanetti, A., Gimbrone, M.A., Jr, Cremona, O., Marchisio, P.C. & Dejana, E. (1992) Human endothelial cells express integrin receptors on the luminal aspect of their membrane. Blood, 80, 437-446.
8. Cramer, E.M., Perlemuter, K., Massè, J.-M. & Debili, N. (1997) Interaction of c7E3 Fab (ReoPro®) with human megakaryocytes. (Abstract). Blood, 90, (Suppl. 1), 26a.
9. Gawaz, M., Neumann, F.J., Dickfeld, T., Reininger, A., Adelsberger, H., Gebbhardt, A. & Schmig. A. (1997) Vitronectin receptor mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation, 96, 1809-1818.
10. Keriades, D.J., Essel, J.H., Abbottsmith, C.W., Broderick, T.M. & Runyon, J.P. (1996) Abciximab-associated profound thrombocytopenia: therapy with immunoglobulin and platelet transfusion. American Journal of Cardiology, 78, 1161-1163.
11. Mascelli, M.A., Lance, E.T., Damaraju, L., Wagner, C.L., Weisman, H.F. & Jordan, R.E. (1998) Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade. Circulation, 97, 1680-1688.
12. Nurden, P., Poujol, C., Durrieu-Jais, C., Winckler, J., Combriè, R., Macchi, L., Bihour, C., Wagner, C., Jordan, R. & Nurden, A.T. (1999) Labeling of the internal pool of GP IIb-IIIa in platelets by c7E3 Fab fragments (abciximab): flow and endocytic mechanisms contribute to the transport. Blood, 93, 1622-1633.
13. 3) in human platelets and megakaryocytes reveals an intracellular pool and labelling of the α-granule membrane. British Journal of Haematology, 97, 823-835.
14. Poujol, C., Tronik-Le Roux, D., Tropel, P., Roullot, V., Nurden, A., Marguerie, G. & Nurden, P. (1998) Ultrastructural analysis of bone marrow hematopoiesis in mice transgenic for the thymidine kinase gene driven by the αIIb promoter. Blood, 92, 2012-2023.
15. Stenberg, P. & Levin, J. (1989) Mechanisms of platelet production. Blood Cells, 15, 23-47.
16. Takahashi, R., Sekine, N. & Nakatake, T. (1999) Influence of monoclonal antiplatelet glycoprotein antibodies on in vitro human megakaryocyte colony formation and proplatelet formation. Blood, 93, 1951-1958.
17. 3 integrins. Circulation, 98, 1085-1091.
18. Tcheng, J.E. (1996) Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE and EPILOG trials into perspective. American Journal of Cardiology, 78, 35-40.